vs

Gen Digital(GEN)与Royalty Pharma plc(RPRX)财务数据对比。点击上方公司名可切换其他公司

Gen Digital的季度营收约是Royalty Pharma plc的2.0倍($1.2B vs $622.0M),Royalty Pharma plc净利率更高(34.4% vs 15.5%,领先19.0%),Gen Digital同比增速更快(28.5% vs 4.8%),过去两年Gen Digital的营收复合增速更高(13.2% vs 4.6%)

Gen Digital是一家跨国软件企业,双总部分别设于美国亚利桑那州坦佩和欧盟捷克布拉格,是财富500强企业及标普500指数成分股,同时在纳斯达克与布拉格证券交易所挂牌上市。公司主营网络安全软件、金融科技及相关服务,旗下拥有诺顿、Avast、LifeLock、AVG、CCleaner等多个知名品牌。

本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业,专注于研发可调节转化生长因子β(TGF-β)超家族蛋白的药物,该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。

GEN vs RPRX — 直观对比

营收规模更大
GEN
GEN
是对方的2.0倍
GEN
$1.2B
$622.0M
RPRX
营收增速更快
GEN
GEN
高出23.7%
GEN
28.5%
4.8%
RPRX
净利率更高
RPRX
RPRX
高出19.0%
RPRX
34.4%
15.5%
GEN
两年增速更快
GEN
GEN
近两年复合增速
GEN
13.2%
4.6%
RPRX

损益表 — Q3 FY2026 vs Q4 FY2025

指标
GEN
GEN
RPRX
RPRX
营收
$1.2B
$622.0M
净利润
$192.0M
$214.2M
毛利率
78.4%
营业利润率
34.9%
62.4%
净利率
15.5%
34.4%
营收同比
28.5%
4.8%
净利润同比
6.1%
2.9%
每股收益(稀释后)
$0.31
$0.49

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
GEN
GEN
RPRX
RPRX
Q1 26
$1.2B
Q4 25
$1.2B
$622.0M
Q3 25
$1.3B
$609.3M
Q2 25
$578.7M
Q1 25
$1.0B
$568.2M
Q4 24
$986.0M
$593.6M
Q3 24
$974.0M
$564.7M
Q2 24
$965.0M
$537.3M
净利润
GEN
GEN
RPRX
RPRX
Q1 26
$192.0M
Q4 25
$134.0M
$214.2M
Q3 25
$135.0M
$288.2M
Q2 25
$30.2M
Q1 25
$142.0M
$238.3M
Q4 24
$159.0M
$208.2M
Q3 24
$161.0M
$544.0M
Q2 24
$181.0M
$102.0M
毛利率
GEN
GEN
RPRX
RPRX
Q1 26
78.4%
Q4 25
78.2%
Q3 25
78.8%
Q2 25
Q1 25
80.3%
Q4 24
80.4%
Q3 24
80.1%
Q2 24
80.3%
营业利润率
GEN
GEN
RPRX
RPRX
Q1 26
34.9%
Q4 25
35.9%
62.4%
Q3 25
35.5%
70.1%
Q2 25
36.3%
Q1 25
41.3%
94.0%
Q4 24
37.9%
60.9%
Q3 24
41.3%
Q2 24
43.2%
50.2%
净利率
GEN
GEN
RPRX
RPRX
Q1 26
15.5%
Q4 25
11.0%
34.4%
Q3 25
10.7%
47.3%
Q2 25
5.2%
Q1 25
14.1%
41.9%
Q4 24
16.1%
35.1%
Q3 24
16.5%
96.3%
Q2 24
18.8%
19.0%
每股收益(稀释后)
GEN
GEN
RPRX
RPRX
Q1 26
$0.31
Q4 25
$0.21
$0.49
Q3 25
$0.22
$0.67
Q2 25
$0.07
Q1 25
$0.22
$0.55
Q4 24
$0.26
$0.46
Q3 24
$0.26
$1.21
Q2 24
$0.29
$0.23

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
GEN
GEN
RPRX
RPRX
现金及短期投资手头流动性
$618.7M
总债务越低越好
$8.4B
$9.0B
股东权益账面价值
$2.3B
$9.7B
总资产
$15.8B
$19.6B
负债/权益比越低杠杆越低
3.61×
0.92×

8季度趋势,按日历期对齐

现金及短期投资
GEN
GEN
RPRX
RPRX
Q1 26
Q4 25
$618.7M
Q3 25
$938.9M
Q2 25
$631.9M
Q1 25
$1.0B
$1.1B
Q4 24
$883.0M
$929.0M
Q3 24
$737.0M
$950.1M
Q2 24
$644.0M
$1.8B
总债务
GEN
GEN
RPRX
RPRX
Q1 26
$8.4B
Q4 25
$8.7B
$9.0B
Q3 25
$8.9B
$8.9B
Q2 25
$8.0B
Q1 25
$8.3B
$7.6B
Q4 24
$8.5B
$7.6B
Q3 24
$8.5B
$7.6B
Q2 24
$8.5B
$7.6B
股东权益
GEN
GEN
RPRX
RPRX
Q1 26
$2.3B
Q4 25
$2.5B
$9.7B
Q3 25
$2.4B
$9.6B
Q2 25
$9.5B
Q1 25
$2.3B
$9.8B
Q4 24
$2.2B
$10.3B
Q3 24
$2.1B
$10.3B
Q2 24
$2.0B
$9.8B
总资产
GEN
GEN
RPRX
RPRX
Q1 26
$15.8B
Q4 25
$16.1B
$19.6B
Q3 25
$16.4B
$19.3B
Q2 25
$18.3B
Q1 25
$15.5B
$17.6B
Q4 24
$15.4B
$18.2B
Q3 24
$15.5B
$18.0B
Q2 24
$15.4B
$17.7B
负债/权益比
GEN
GEN
RPRX
RPRX
Q1 26
3.61×
Q4 25
3.54×
0.92×
Q3 25
3.75×
0.93×
Q2 25
0.84×
Q1 25
3.64×
0.78×
Q4 24
3.94×
0.74×
Q3 24
4.06×
0.74×
Q2 24
4.33×
0.78×

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
GEN
GEN
RPRX
RPRX
经营现金流最新季度
$827.1M
自由现金流经营现金流 - 资本支出
自由现金流率自由现金流/营收
资本支出强度资本支出/营收
现金转化率经营现金流/净利润
3.86×
过去12个月自由现金流最近4个季度

8季度趋势,按日历期对齐

经营现金流
GEN
GEN
RPRX
RPRX
Q1 26
Q4 25
$541.0M
$827.1M
Q3 25
$409.0M
$702.6M
Q2 25
$364.0M
Q1 25
$473.0M
$596.1M
Q4 24
$326.0M
$742.5M
Q3 24
$158.0M
$703.6M
Q2 24
$264.0M
$658.2M
自由现金流
GEN
GEN
RPRX
RPRX
Q1 26
Q4 25
$535.0M
Q3 25
$405.0M
Q2 25
Q1 25
$470.0M
Q4 24
$318.0M
Q3 24
$156.0M
Q2 24
$262.0M
自由现金流率
GEN
GEN
RPRX
RPRX
Q1 26
Q4 25
43.9%
Q3 25
32.2%
Q2 25
Q1 25
46.5%
Q4 24
32.3%
Q3 24
16.0%
Q2 24
27.2%
资本支出强度
GEN
GEN
RPRX
RPRX
Q1 26
Q4 25
0.5%
Q3 25
0.3%
Q2 25
Q1 25
0.3%
Q4 24
0.8%
Q3 24
0.2%
Q2 24
0.2%
现金转化率
GEN
GEN
RPRX
RPRX
Q1 26
Q4 25
4.04×
3.86×
Q3 25
3.03×
2.44×
Q2 25
12.06×
Q1 25
3.33×
2.50×
Q4 24
2.05×
3.57×
Q3 24
0.98×
1.29×
Q2 24
1.46×
6.45×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

GEN
GEN

Cyber Safety Platform$819.0M66%
Trust Based Solutions$421.0M34%
Net Interest Income On Notes Receivable$4.0M0%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

相关对比